2026-08-11 · 2026-08 / week-2
Monday.com Prices a Growth Haircut, Not a Cash Break
Monday.com Prices a Growth Haircut, Not a Cash Break
Summary: monday.com (NASDAQ: MNDY) closed at $88.62 on August 10, 2026, down 4.84% from the prior session on 2.9x its recent average volume. The market may be pricing a permanent growth and capital-return reset after management guided third-quarter revenue growth to 16% to 17%, completed its entire $870 million repurchase authorization, and reported first-half operating cash flow and adjusted free cash flow below the prior year. The latest primary release still shows 22% second-quarter revenue growth, 109% net dollar retention, 27% current remaining-performance-obligation growth, 17% non-GAAP operating margin, and AI-product ARR that doubled from Q1. The disagreement is real but not clean enough for a price-specific entry. This is a conditional U.S. common-stock Watchlist long, not personalized financial advice.
Research timestamp: 2026-08-11 09:44:23 Vietnam time, UTC+07:00. The latest verified U.S. regular-session market reference was $88.62 at 2026-08-10 20:00:02 UTC. The reference is not an executable entry.
Evidence labels: The monday.com Q2 FY26 release, the prior Q1 FY26 release, and the historical market record are facts. The claim that the price has over-discounted a growth haircut, the target levels, the probabilities, and the causal interpretation of the selloff are judgmental inferences. Live short interest, borrow, options, dealer-flow, fund-flow, bid-ask spread, order-book depth, venue quality, and exit liquidity were not independently verified.
Opportunity Ranking
This run was explicitly limited to U.S.-listed long opportunities. I scanned the current articles/2026-08/week-2/ folder and the full repository by ticker, issuer, segment, mechanism, and prior direction before selecting a name. No prior monday.com or MNDY article was found. The discovery queries used combinations such as "AI ARR" "net dollar retention" "repurchase exhausted", "RPO growth" "free cash flow decline" "software selloff", "enterprise SaaS" "buyback complete" "cash balance", and "growth haircut" "current remaining performance obligations". These searches were designed to find a disagreement inside a fresh filing, not a generic earnings list.
| Rank | Candidate | Market reference and fresh evidence | Catalyst path | Greater-than-5% move case | Why it ranked here | Why it ranked lower or was rejected |
|---|---|---|---|---|---|---|
| 1 | MNDY long | $88.62, down 4.84% on August 10, with 4.819 million shares traded. Q2 revenue grew 22%; Q3 revenue guidance is $368 million to $370 million, or 16% to 17% growth; cRPO grew 27% | Next quarterly release, AI-product ARR conversion, enterprise NDR, RPO and cRPO, margin, cash flow, and diluted-share disclosure | A guide hold with continued enterprise expansion can recover part of the growth haircut; a guide cut or retention break can retest the 52-week low | It has post-release primary evidence, a visible price reset, a measurable operating bridge, and a cleaner balance sheet than the AI-infrastructure alternatives | The buyback is finished, first-half cash fell, and the next growth rate is lower than Q2 |
| 2 | CRWV long | $88.19, down 2.73% in the screen snapshot, with roughly 20.9 million shares traded. Q1 revenue was $2.078 billion and reported revenue backlog was $99.4 billion, but Q1 net loss was $740 million and interest expense was $536 million | Q2 results after the close on August 11 and subsequent debt, capex, delivery, and cash-flow disclosures | Backlog conversion can move the stock sharply, but a loss, interest burden, and capital intensity create symmetric event risk | Strong demand disagreement and urgent catalyst | The backlog-to-cash bridge is materially less proven and the capital structure can dominate the equity |
| 3 | ETOR long | $34.00, down 3.51% in the screen snapshot. Q1 net contribution was $258 million, adjusted EBITDA $109 million, and funded accounts 4.02 million | Q2 results before the August 11 open, then assets-under-administration, trading activity, net contribution, and cash conversion | A strong activity and AUA print can move a high-beta platform more than 5% | Fresh catalyst and observable operating metrics | Q2 evidence was not yet available; activity is sensitive to market conditions and retail-trading behavior |
| 4 | LITE long | $813.51, down 8.58% in the screen snapshot, with reported finance-feed P/E near 146.8x. Q4 results were due after the August 11 close | Optical demand, margin, and guidance after the close | The event can create a large move in either direction | Immediate catalyst and large tape response | The valuation leaves little room for an execution miss, and the evidence is binary before the release |
MNDY wins because it has the best combination of fresh evidence, a visible price disagreement, measurable enterprise and cash tests, and a less encumbered balance sheet. CRWV has more headline optionality but a harder financing bridge. ETOR has a cleaner event window but no Q2 evidence yet. LITE has the strongest single-day price move but the least forgiving valuation. This is a ranking by asymmetry, evidence freshness, catalyst urgency, positioning tension, surprise potential, and tradeability, not a ranking of company quality.
Why This Is the Best Opportunity Right Now
The strongest counterargument comes first: the market may be correct. Q2 revenue growth of 22% is already expected to slow to 16% to 17% in Q3. The company has spent the entire $870 million repurchase authorization, so the visible issuer bid is gone. First-half operating cash flow fell to $160.0 million from $178.8 million, and adjusted free cash flow fell to $155.1 million from $173.6 million. Cash and cash equivalents declined by about $650 million from December 31, even after marketable securities rose. AI-product ARR doubling from Q1 is a small-base growth signal, not proof of a new revenue engine. A restructuring charge, foreign-exchange exposure, and the absence of future buyback capacity give the market several rational reasons to apply a lower multiple.
The narrower long inference is that the market may be pricing a break in the core enterprise engine when the latest evidence shows a growth haircut without a retention or contract-value collapse. Customers with more than $100,000 of ARR grew 37% year over year, their NDR was 115%, cRPO grew 27%, and non-GAAP operating margin reached 17% despite an adverse foreign-exchange impact. That does not make MNDY cheap. It creates a testable disagreement: the next growth rate is lower, but the higher-value customer cohorts and contracted revenue indicators have not yet broken.
The cheapest way to falsify the long case is the next quarterly bridge. It must show whether Q3 guidance is conservative, whether AI products add net new ARR rather than re-label existing demand, and whether cash flow can coexist with the end of capital returns.
Why This Can Jump or Dump More Than 5% Soon
Fact: MNDY closed at $88.62 on August 10, versus a $93.13 prior close. It opened at $81.40, traded as low as $80.24, reached $88.97, and closed near the top of the session range on 4.819 million shares. The prior 20-session average volume calculated from the Yahoo historical series was approximately 1.659 million shares, making the session about 2.9x that average. The regular-session reference is documented in the Yahoo chart record.
Upside inference: If the next release holds the $368 million to $370 million Q3 revenue guide, keeps non-GAAP operating income near the $57 million to $59 million guide, and shows cRPO, NDR, AI ARR, and cash conversion remaining healthy, the stock can recover toward the base case. A move from $88.62 to $105 would be approximately 18.5%.
Downside inference: If Q3 revenue guidance is cut, NDR falls toward or below 105%, cRPO growth slows materially, or adjusted free cash flow guidance is reduced, the stock can retest the $57.50 52-week low. A move to the bottom case of $60 would be approximately 32.3% lower than the reference. The downside does not require a liquidity crisis. A slower growth engine combined with no buyback support is enough.
Unknown: The tape proves that the stock was active and recovered from its opening low. It does not identify the marginal buyer or seller, prove a squeeze, or establish reliable exit liquidity.
What Should Surprise a Sophisticated Reader
The obvious story is that AI ARR doubled. The more important fact is the denominator: the release says AI products represented 17% of net new ARR in Q2, not 17% of total revenue or total ARR. The signal is meaningful, but it is not yet a dollar revenue bridge.
The second surprise is that enterprise quality improved while the headline growth rate is slowing. Customers with more than $50,000 of ARR grew 31%, customers with more than $100,000 grew 37%, and customers with more than $500,000 grew 68%. Those cohorts represented 43%, 30%, and 7% of ARR, respectively. NDR was 115% for both the more-than-$50,000 and more-than-$100,000 cohorts. The market can still decide that 16% to 17% growth is not enough, but the filing does not show a broad enterprise contraction.
The third surprise is capital-return finality. The company repurchased approximately 2.333 million shares for about $182 million in Q2 and had used the entire $870 million authorization by quarter-end. The issuer is not a continuing buyer under that program. A completed buyback reduces the historical denominator, but it is not future support, and the first-half cash-flow statement shows the cost of the completed return.
The Setup
monday.com's Q2 release supplies four separate states:
- Operating growth: Q2 revenue was $364.6 million, up 22% year over year. GAAP operating loss narrowed to $1.5 million from $11.6 million, while non-GAAP operating income rose to $61.1 million and non-GAAP operating margin reached 17%.
- Enterprise quality: Overall NDR was 109%. NDR was 113% for customers with more than 10 users and 115% for both the more-than-$50,000 and more-than-$100,000 ARR cohorts.
- Contract visibility: Total RPO was $937 million, up 34%, and cRPO was $750 million, up 27%.
- AI transition: ARR from AI products doubled from Q1 and represented 17% of net new ARR in Q2. The release does not disclose a standalone AI revenue or total AI ARR dollar bridge.
| Q2 2026 measure | Reported result | Why it matters |
|---|---|---|
| Revenue | $364.6M, +22% year over year | The price reset did not follow a reported revenue contraction |
| Non-GAAP operating income | $61.1M | Operating leverage improved despite FX pressure |
| Non-GAAP operating margin | 17% | The next guide implies approximately 16%, a real but bounded haircut |
| Overall NDR | 109% | The core base still expands, though less than a hyper-growth profile |
| NDR, customers above $100k ARR | 115% | Higher-value cohorts are not yet showing a retention break |
| RPO / cRPO | $937M / $750M | Contracted future revenue grew faster than reported revenue |
| AI ARR contribution | 17% of net new ARR | Important adoption evidence, not a total-revenue bridge |
The guidance is where the market's haircut becomes visible:
| Guide | Q3 FY26 | FY26 | Interpretation |
|---|---|---|---|
| Revenue | $368M to $370M, +16% to +17% | $1.466B to $1.474B, +19% to +20% | Growth moderates, but the company did not cut the full-year revenue range |
| Non-GAAP operating income | $57M to $59M, about 16% margin | $230M to $234M, about 16% margin | Profitability is guided to hold near the new cost structure |
| Adjusted free cash flow | Not separately guided for Q3 | $280M to $290M, 19% to 20% margin | Forecast, not cash already earned |
Cash, Capital Return, and Denominator
The cash bridge is the strongest reason not to call MNDY a simple value long.
| Measure | Q2 or H1 2026 | Prior comparison | Interpretation |
|---|---|---|---|
| Q2 operating cash flow | $55.4M | $66.8M in Q2 2025 | Positive cash, but lower year over year |
| Q2 adjusted free cash flow | $52.3M | $64.1M in Q2 2025 | The cash-quality evidence weakened |
| H1 operating cash flow | $160.0M | $178.8M in H1 2025 | The decline is not limited to one quarter |
| H1 adjusted free cash flow | $155.1M | $173.6M in H1 2025 | Margin fell to 22% from 30% |
| Cash and equivalents | $853.4M at June 30 | $1.503B at December 31 | Cash declined materially |
| Marketable securities | $219.4M at June 30 | $162.3M at December 31 | Liquid assets are not the same as uncommitted cash |
| H1 repurchase cash | $735.0M | No prior-year repurchase in the comparison | Completed capital return consumed cash |
| H1 share-based compensation | $70.5M | $87.6M in H1 2025 | Non-cash, but relevant to per-share economics |
| Q2 restructuring charge | $21.4M | None in Q2 2025 | Non-cash impairment tied to the broader restructuring plan |
The company had no bank-debt line item in the condensed June 30 balance sheet, but it did report approximately $237.5 million of operating lease liabilities and $1.002 billion of total liabilities, including $454 million of current deferred revenue. The cash decline therefore cannot be read as a debt crisis, but neither can the cash balance be treated as fully distributable. Deferred revenue is a customer obligation, and leases are a contractual claim.
The release also approves a Q3 donation of 196,829 ordinary shares to the monday.com Foundation. It is not economically comparable to the repurchase, but it is part of the next share-count bridge. The next filing should reconcile repurchased shares, option exercise, share-based compensation, the donation, and diluted shares.
Price
| Field | Observation |
|---|---|
| Latest regular-session reference | $88.62 |
| Regular-session timestamp | 2026-08-10 20:00:02 UTC, or 2026-08-11 03:00:02 Vietnam time |
| Prior close | $93.13 |
| Session change | -4.84% |
| Open / high / low | $81.40 / $88.97 / $80.24 |
| Session volume | 4.819M shares |
| Prior 20-session average volume | Approximately 1.659M shares |
| Volume multiple | Approximately 2.9x |
| 52-week high / low | $220.80 / $57.50 |
| Drawdown from 52-week high | Approximately -59.9% |
| Finance-feed market capitalization | Approximately $4.336B, screening reference only |
| Execution status | No price-specific entry. Same-session spread, depth, venue, volume quality, and exit liquidity were not verified |
The historical close, range, volume, and 52-week fields come from the Yahoo Finance chart series. The finance-feed market capitalization is a screening field. It is not used as a definitive valuation measure because current settled shares after the completed repurchase and the latest filed share data do not provide a clean, same-timestamp enterprise-value bridge.
Positioning
Observed: The stock sold off from the prior close, opened near $81, and recovered most of the session loss on nearly three times its recent average volume. This is evidence of a two-sided, active tape. It is not evidence of accumulation, forced covering, or a short squeeze.
Observed issuer flow: The company repurchased approximately 2.333 million shares in Q2. That is historical settled demand. The authorization is now fully used, so it cannot be treated as a standing floor.
Missing: Live short interest, borrow availability and cost, options open interest and implied volatility, dealer positioning, fund flows, ETF flows, NBBO spread, order-book depth, venue quality, and exit liquidity were not verified. Positioning is capped at 3/5. No squeeze claim or options expression is used.
The positioning disagreement is therefore modest: the price action says expectations reset, while the filing says the enterprise cohorts and contractual revenue indicators have not yet broken. The next quarter, not a volume interpretation, decides which reading is correct.
Catalyst
- Q3 guide delivery: The next quarterly release must reconcile revenue against the $368 million to $370 million guide and non-GAAP operating income against the $57 million to $59 million guide.
- Enterprise durability: Track NDR for customers above 10 users, $50,000 ARR, and $100,000 ARR. A lower total growth rate is more survivable if the higher-value cohorts retain and expand.
- RPO and AI conversion: Track RPO, cRPO, AI-product ARR, and the share of net new ARR from AI products. The key question is whether AI expands total wallet share or simply changes product labels.
- Cash conversion: Track operating cash flow, adjusted free cash flow, capex, marketable-security purchases, and cash after the end of the repurchase program.
- Denominator evidence: Track the next diluted share count, the Q3 foundation donation, option exercise, and any new capital-return action. There is currently no remaining repurchase authorization under the disclosed program.
- Restructuring follow-through: The next filing should separate one-time restructuring cash and non-cash costs from recurring sales, marketing, research, and headquarters costs.
The cheapest disconfirming sequence is the next quarterly release and call, followed by the next balance-sheet and cash-flow filing. The practical test is not “did AI grow?” It is “did higher-value customers, cRPO, operating margin, and cash flow survive the lower growth guide?”
The Mispricing
The market appears to be applying a growth haircut, but the evidence does not yet establish a cash break or an enterprise-retention break.
Fact: Q2 revenue grew 22%, non-GAAP operating margin reached 17%, cRPO grew 27%, and higher-value customer cohorts reported NDR of 115%.
Fact: Q3 revenue guidance is 16% to 17% growth, H1 operating cash flow and adjusted free cash flow declined, the buyback program is exhausted, and cash fell from December 31.
Inference: A large part of the selloff may be a rational repricing of the future growth and capital-return profile. The possible mispricing is narrower: the market may be treating a lower growth rate as evidence that the enterprise engine and AI transition have already failed.
Unknown: The release does not show the standalone dollar amount of AI ARR, customer-level AI expansion, sales efficiency, or the next-quarter cash bridge. The growth haircut can therefore be correct even if the reported cohort metrics are healthy.
This is why the setup is a Watchlist and not an active trade. The weighted price-only value is positive, but the edge is not wide enough to overcome missing market-structure evidence and an unresolved cash-return transition.
Payoff Map
The scenarios use the $88.62 reference and a three-to-nine-month horizon. They are judgmental price levels, not forecasts or instructions to buy.
The top case requires the Q3 guide to hold, NDR and cRPO to remain healthy, AI-product ARR to continue contributing net new ARR, and the market to restore part of the growth multiple. The base case assumes a slower but still profitable platform with no new buyback support. The bottom case assumes the market's haircut is correct and that the next release shows a growth, retention, or cash-flow break.
Price Target and Probability Map
| Scenario | Probability | Target / level | Return / payoff | Time horizon | Conditions required | Evidence quality |
|---|---|---|---|---|---|---|
| Top case | 25% | $125 | +41.2% | 3 to 9 months | Q3 guide holds or rises; enterprise NDR remains above 110%; cRPO stays above 20% growth; AI products add net new ARR; FY26 FCF guide is preserved | Medium. Q2 evidence is filed; durability is unproven |
| Base case | 50% | $105 | +18.5% | 3 to 9 months | Growth settles in the high teens, operating margin remains near 16%, and the market accepts the end of buyback support without a cohort break | Medium. Guidance is filed; multiple recovery is uncertain |
| Bottom case | 25% | $60 | -32.3% | 1 to 6 months | Q3 guide cut, NDR at or below 105%, cRPO growth below 15%, FCF guide cut, or restructuring and AI investment weaken cash conversion | Medium. The mechanism is clear; the exact price is a stress level |
| Invalidation / review | n/a | Review after a fundamental break | Not a price-only stop | Same horizon | Two consecutive quarters of NDR at or below 105%, cRPO growth below 15% plus a guide or FCF cut, or a new balance-sheet constraint | High for the rule, low for the future outcome |
Probability check: 25% + 50% + 25% = 100%.
Probability-weighted price value: (0.25 x $125) + (0.50 x $105) + (0.25 x $60) = $98.75, or approximately +11.4% versus the reference before fees, taxes, slippage, financing costs, and gap risk.
This is a price-only expected value, not an executable enterprise value. A current EV cannot be computed with high confidence because the finance-feed market capitalization, post-repurchase settled share count, latest filed diluted count, operating lease claims, and customer-deferred-revenue obligations are not a same-timestamp valuation bridge. The modest positive price-only result is not sufficient to authorize a trade.
What Would Prove This Wrong
The long thesis fails if the next filing shows a broad deterioration in the higher-value cohorts, not merely a lower total growth rate. The clearest break would be NDR at or below 105% for two quarters, cRPO growth below 15% alongside a revenue or FCF guide cut, or an AI-product adoption figure that fails to translate into net new ARR.
It also fails if cash and marketable securities continue to fall without a corresponding operating or strategic investment return, if operating margin falls materially below the approximately 16% guide without a clearly disclosed reinvestment plan, or if the share-count bridge shows that compensation and the planned donation offset most of the repurchase effect.
A price print below $57.50 with one of these fundamental breaks is a review and exit condition. A price-only print below the 52-week low is not proof that the thesis is wrong. Likewise, a recovery above $105 without better NDR, cRPO, AI ARR, margin, and cash-flow evidence is not confirmation.
Risk Audit
The strongest counterparty says the market has finally recognized that monday.com is a maturing software platform. The Q3 growth guide is materially below Q2, the repurchase program is finished, and management is changing the cost structure. The market does not need to believe that the product is broken. It only needs to believe that a high-teens growth company with lower capital-return support deserves a lower multiple.
That counterargument is stronger than a generic valuation objection because the cash statement supports part of it. H1 adjusted FCF fell to $155.1 million, H1 repurchases consumed $735.0 million, and cash and equivalents declined to $853.4 million. The company cannot buyback its way through a slower-growth period under the completed authorization.
| Risk | Why it matters | Control |
|---|---|---|
| Growth deceleration | Q3 growth guidance is 16% to 17%, below Q2's 22% | Require the next two revenue and cohort disclosures before upgrading |
| AI adoption quality | AI ARR doubled from Q1 but the dollar base and standalone revenue are not disclosed | Track AI contribution to net new ARR and total ARR, not slogans |
| Retention | Overall NDR is 109%, not a hyper-growth number | Track NDR by customer size and require a clear enterprise trend |
| Cash conversion | H1 OCF and adjusted FCF fell year over year | Reconcile cash, marketable securities, capex, working capital, and FCF guide |
| Buyback exhaustion | The $870M authorization is fully used | Treat historical purchases as denominator evidence, not future demand |
| Dilution and share count | SBC was $70.5M in H1 and 196,829 shares are planned for foundation donation | Reconcile diluted shares, option exercise, SBC, and donation in the next filing |
| Restructuring and FX | The Q2 release includes a $21.4M restructuring charge and guide assumptions include negative FX | Separate recurring costs from one-time charges and track FX impact |
| Market structure | A wide spread, shallow depth, gap, or weak exit liquidity can dominate a correct thesis | Use staged limits only after a same-session market-structure review |
| Israel and foreign-issuer risk | monday.com is incorporated in Israel and reports FX and regional operating exposure | Treat geopolitical, FX, and reporting risks as live uncertainty |
Best Trade Strategy
- Direction: Conditional long, Watchlist only.
- Preferred instrument: MNDY common stock on Nasdaq.
- Common-stock stance: The $88.62 close is a reference price. A staged, limit-only common-stock expression can be reviewed only after a fresh regular-session quote, bid-ask spread, order-book depth, venue status, volume quality, and exit-liquidity review. The entry price remains null.
- Execution status: execution.can_execute=false. Locate and borrow are not the ordinary constraint for an unlevered long, but live market-structure evidence is required before a price-specific entry. Missing live short interest, borrow, options, dealer-flow, and fund-flow data caps positioning at 3/5.
- Options stance: No options expression. The live chain, implied volatility, open interest, dealer positioning, and spread quality were not verified. No leverage or derivative expression is authorized by this research.
- Take-profit map: Review near $105 in the base case and $125 in the top case only if the next guide, NDR, cRPO, AI ARR, margin, and cash bridge support the move.
- Stop or invalidation: Review near $60 only when paired with a guide, retention, cRPO, FCF, margin, or balance-sheet break. A price-only stop cannot diagnose the thesis.
- Timeline: The next quarterly release and call, followed by the next 10-Q or equivalent balance-sheet and share-count filing. The exact next earnings date was not verified.
- Execution risks: Opening gap, stale quote, wide spread, shallow depth, venue or halt risk, weak exit liquidity, post-event volatility, FX headlines, and the possibility that multiple compression occurs before a staged order fills.
- Do-not-trade conditions: No fresh regular-session quote; no reliable spread, depth, venue, volume-quality, or exit-liquidity review; a Q3 guide cut; NDR at or below 105%; cRPO growth below 15%; an FCF guide cut; an unexplained margin break; a new financing need; or any request to use options, leverage, margin, or a market order without verified live data.
- Monitoring checklist: Q3 revenue; non-GAAP and GAAP operating margin; NDR by customer cohort; RPO and cRPO; AI-product ARR and net-new-ARR contribution; operating cash flow; adjusted FCF; cash and marketable securities; capex and headquarters costs; restructuring; diluted shares; SBC; foundation donation; and fresh market-structure data before entry.
Bottom Line
monday.com has not proven that the market's growth haircut is wrong. It has proven something narrower: Q2 growth slowed in the forward guide, but higher-value customer cohorts, cRPO, operating margin, and AI-product adoption remained constructive. The market may be pricing a product and cash-flow break before the next filing demonstrates one.
The counterweight is decisive. H1 cash conversion weakened, the entire buyback authorization is gone, SBC remains material, the restructuring is not costless, and a 16% to 17% growth guide may deserve a lower multiple. The price-only probability map is modestly positive at approximately $98.75, but current EV and executable entry are not verified.
The correct desk posture is a conditional MNDY common-stock Watchlist, no options, no leverage, no price-specific entry, and fail-closed execution. The next quarterly customer-cohort, cRPO, AI ARR, margin, cash-flow, and share-count bridge decides whether the selloff was a rational growth reset or an overreaction to a still-compounding enterprise platform.
Research Quality Scorecard
| Criterion | Score | Rationale |
|---|---|---|
| Market disagreement | 5/5 | The price reset is set against filed enterprise retention, cRPO, margin, and AI-product evidence |
| Evidence base | 5/5 | Q2 primary release, prior guide, balance-sheet and cash-flow tables, and timestamped market data are identified |
| Positioning and flows | 3/5 | Price, volume, and completed repurchase are observable; live positioning and liquidity data are missing |
| Catalyst path | 4/5 | The next quarterly operating, cash, AI ARR, cRPO, and share-count disclosures are clear, but the exact date is unverified |
| Payoff architecture | 4/5 | Scenarios are explicit and weighted, but the multiple and cash-return transition limit confidence |
| Invalidation discipline | 5/5 | Cohort, cRPO, guide, FCF, margin, share-count, and price-review controls are separated |
| Differentiated insight | 5/5 | The article separates AI adoption, enterprise quality, growth rate, cash conversion, and buyback finality |
| Client value | 4/5 | The monitoring sequence is useful even when execution is unavailable |
| Total | 35 / 40 | Publishable as a conditional Watchlist long, not an executable trade |
The section-17 quality gate is answered yes for a specific mispricing, primary evidence, clearly labeled positioning uncertainty, a catalyst path, an honest downside case, the strongest counterargument, usefulness without a trade, sourced factual claims, non-hype language, opportunity ranking, greater-than-5% move logic, surprise factor, a 100% probability map, a dedicated scorecard, Markdown tables, an inline illustration prompt, Best Trade Strategy, technical-signal independence, and explicit missing-data notes. The user explicitly scoped this run to U.S. markets, so Japan, broader Asia, and Europe / UK were not activated.
Sources and Data Audit
| Source | Tier | Date / timestamp | Use |
|---|---|---|---|
| monday.com Q2 FY26 financial results | Primary company release | June 30 quarter, published August 10, 2026 | Revenue, margin, NDR, customer cohorts, RPO, cRPO, AI ARR, repurchase completion, guidance, cash flow, cash, liabilities, SBC, restructuring, and share donation |
| monday.com Q1 FY26 results | Primary company release | Q1 FY26 | Prior revenue, operating-income, and FCF guide for the guide-change comparison |
| MNDY Yahoo historical chart | Market data | Regular-session close through August 10, 2026 20:00:02 UTC | Close, prior close, session range, volume, 52-week range, and prior-20-session volume comparison |
| MNDY Yahoo quote page | Market data | Screen snapshot around August 11, 2026 00:15 UTC | Market-cap reference and quote cross-check; not an executable entry |
| CoreWeave Q1 FY26 results | Primary company release | Q1 FY26 | Ranked alternative: backlog, revenue, loss, interest expense, and AI infrastructure cash-quality context |
| CoreWeave Yahoo quote page | Market data | Screen snapshot around August 11, 2026 00:15 UTC | Ranked alternative price and volume reference |
| eToro Q2 FY26 reporting notice | Primary company notice | August 11, 2026 event | Ranked alternative catalyst timing |
| eToro Q1 FY26 results | Primary company release | Q1 FY26 | Ranked alternative net contribution, EBITDA, and funded-account context |
| eToro Yahoo quote page | Market data | Screen snapshot around August 11, 2026 00:15 UTC | Ranked alternative price and volume reference |
| Lumentum FY26 reporting date | Primary company notice | August 11, 2026 event | Ranked alternative catalyst timing |
| Lumentum Yahoo quote page | Market data | Screen snapshot around August 11, 2026 00:15 UTC | Ranked alternative price, volume, and finance-feed valuation reference |
AI Illustration Prompt
Create a restrained, high-end institutional editorial illustration for The Mispricing Desk about monday.com: an enterprise software platform whose share price has taken a growth haircut while its retention and contract-value bridges remain intact. Show a dark graphite work-management control room with layered workflow panels and a calm blue current labelled "Q2 revenue $364.6M", "NDR 109%", and "cRPO $750M, +27%". In the foreground, place two separate ledgers: one bright but unfinished AI adoption ledger marked "AI ARR 17% of net new ARR", and one depleted capital-return ledger stamped "$870M authorization fully used". Add a narrow amber bridge labelled "Q3 guide, NDR, cRPO, cash", with one missing segment representing the unverified next-quarter evidence. Include a smaller cash panel reading "H1 OCF $160M", "H1 adjusted FCF $155M", and "cash $853M". Use graphite, deep navy, paper white, steel blue, muted green, amber, and one controlled red execution accent. The mood should be analytical, sober, institutional, and unresolved, like a Bloomberg Markets, Barron's, or The Economist cover. Avoid rockets, memes, casino imagery, generic candlestick charts, cartoon money, people in focus, and promotional AI clichés. Add a subtle semi-transparent "The Mispricing Desk" watermark in the lower-right corner.